Johnson & Johnson settles opioid case in New York, will pay up to $230 million and stop selling deadly drugs in US

Sharing is Caring!
Johnson & Johnson has agreed to cough up a settlement of up to $230 million and stop selling opioids in the US. The sum is a drop in the ocean for the firm, but comes as nationwide trials could see payouts in the billions.

“Johnson & Johnson will pay up to $230 million for its role in fueling the opioid crisis that has devastated communities across New York,” the state’s attorney general, Letitia James, announced on Saturday. The settlement excludes the drugmaker from an upcoming lawsuit charging multiple opioid manufacturers and distributors with deceptively marketing these addictive painkillers and downplaying the threat of addiction.

See also  CAUGHT: $7.2 Million GIFT to Pelosi Gets Exposed


See also  Unrestricted Mass Border Invasion Continues, REPORT: 1 Million Illegal Entries in June, With 20,000 in Rio Grand Valley Sector Last Week Alone


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.